TLPH Q1 2023 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$5M

Net Income

-$8M

EPS (Diluted)

$-0.75

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$569,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$12M

Stockholders' Equity

$14M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$41,000	-2453.7%
Operating Income	-$5M	-$5M	-7.9%
Net Income	-$8M	-$9M	+6.0%